Eli Lilly, Gilead favorites at BofA ahead of Q3 earnings


Symbol for the 3rd Quarter of the year. Hand turns dice and changes the expression Q2 to Q3.


Heading into the biopharma Q3 earnings season, Bank of America has taken a bullish stance on Eli Lilly (NYSE:LLY) and Gilead (NASDAQ:GILD) while raising concerns on COVID-era favorites such as Pfizer (NYSE:PFE) and Regeneron (NASDAQ:REGN).

The end of the pandemic

Source link

Leave A Reply

Your email address will not be published.